1 The Kirby Institute, UNSW Sydney, Kensington, NSW, 2052, Australia.
2 Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Faculté de Pharmacie, Malaria Research and Training Center (MRTC), Point G, PB1805, Bamako, Mali.
3 Medicinal Chemistry & Drug Design Global Research & Development, Discovery Technologies, Merck Healthcare, 64293, Darmstadt, Germany.
4 Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
5 Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York, NY, 10032, USA.
6 Global Health Institute of Merck, Ares Trading S.A., (an affiliate of Merck KGaA, Darmstadt, Germany), 1262, Eysins, Switzerland.
7 Weill Cornell Medical College, New York, NY, 10021, USA.
9 Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, DD1 4HN, Scotland, UK.
10 Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Faculté de Pharmacie, Malaria Research and Training Center (MRTC), Point G, PB1805, Bamako, Mali. laurent@icermali.org.
11 Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, 10032, USA. df2260@cumc.columbia.edu.
12 Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York, NY, 10032, USA. df2260@cumc.columbia.edu.
13 Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA. df2260@cumc.columbia.edu.
14 The Kirby Institute, UNSW Sydney, Kensington, NSW, 2052, Australia. dkhoury@kirby.unsw.edu.au.
15 Global Health Institute of Merck, Ares Trading S.A., (an affiliate of Merck KGaA, Darmstadt, Germany), 1262, Eysins, Switzerland. thomas.spangenberg@merckgroup.com.